[Lupus membranous nephropathy].
The systemic lupus erythematosus associated renal hystopathological complexity and its clinical translation, are still a diagnostic challenge with therapeutical implications which, however, include new options in the last few years within the immunosupression compass. The new insights elicited by research work attempt to give some light on renal biopsy performance, its relationship with the arrogated clinical spectrum, its prognosis and on the lupus nephropathy new treatments currently under ongoing clinical trials, some of them showing encouraging results. The lupus membranous nephropathy, recognized as an anatomopathological entity more than 4 decades ago, means a specific pattern in the whole renal lupus histologycal range and, in many aspects, an etiopathogenic enigma.
Hospital Virgen de la Luz, Cuenca, España. jcbermell@sescam.jccm.es
Juan Carlos
JC
Bermell Serrano
D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008181:Lupus Nephritis / Q000188:drug therapy / Q000473:pathology
D007166:Immunosuppressive Agents